Stocks for Hims & Hers fell on Monday after the company pulled its $49 weight loss pill that's under FDA scrutiny.
Breakdown
- Hims & Hers stock fell over 16% after halting weight loss pill sales 18s
- FDA cracked down on compounded drugs; Novo Nordisk filed a lawsuit 46s
- Pill used GLP-1 ingredients and was cheaper than name brands 37s
- Stock closed at $19, down from $68 last year 1m 7s
- Hims & Hers claims Big Pharma is limiting consumer choice 1m 41s